The Biomarker for CKD: Urinary L-Fabp ― From Molecular Function to Clinical Significance

Folia Pharmacologica Japonica- Japan

doi 10.1254/fpj.146.27

Full Text

Abstract

Available in

Categories

Date

January 1, 2015

Authors

Masateru Okazaki

Tsuyoshi Oikawa

Publisher

Japanese Pharmacological Society

Related search

Clinical Significance of Urinary L-Fabp in the Emergency Department

International Journal of Emergency Medicine

Emergency Medicine

English

Urinary I-Fabp, L-Fabp, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease

Journal of Immunology Research

English

Association Between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Preface to the “CKD Clinical Practice Guidebook”

Clinical and Experimental Nephrology

English

Clinical Significance of Serum and Urinary Β2-Microglobulin

English

The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD

Journal of the American Society of Nephrology : JASN

English

Defining the Clinical Significance of Alloscardovia Omnincolens in the Urinary Tract

Journal of Clinical Microbiology

English

Chapter 1. Significance of CKD

Clinical and Experimental Nephrology

English

Molecular Epidemiology and Clinical Significance of Corynebacterium Striatum Isolated From Clinical Specimens [Corrigendum]

Infection and Drug Resistance

Infectious Diseases

English